GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elekta AB (OTCPK:EKTAF) » Definitions » ROE % Adjusted to Book Value

Elekta AB (Elekta AB) ROE % Adjusted to Book Value : 4.22% (As of Jan. 2024)


View and export this data going back to . Start your Free Trial

What is Elekta AB ROE % Adjusted to Book Value?

Elekta AB's ROE % for the quarter that ended in Jan. 2024 was 12.21%. Elekta AB's PB Ratio for the quarter that ended in Jan. 2024 was 2.89. Elekta AB's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2024 was 4.22%.


Elekta AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Elekta AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elekta AB ROE % Adjusted to Book Value Chart

Elekta AB Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.82 3.29 3.06 4.58 2.87

Elekta AB Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.17 6.67 2.93 4.66 4.22

Competitive Comparison of Elekta AB's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Elekta AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elekta AB's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elekta AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Elekta AB's ROE % Adjusted to Book Value falls into.



Elekta AB ROE % Adjusted to Book Value Calculation

Elekta AB's ROE % Adjusted to Book Value for the fiscal year that ended in Apr. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=9.73% / 3.39
=2.87%

Elekta AB's ROE % Adjusted to Book Value for the quarter that ended in Jan. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=12.21% / 2.89
=4.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elekta AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Elekta AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Elekta AB (Elekta AB) Business Description

Address
Kungstensgatan 18, Box 7593, Stockholm, SWE, SE-103 93
Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company's installed base of more than 5,000 linear accelerators, GammaKnife and Unity platforms, and software is used in more than 6,000 hospitals globally. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and Asia-Pacific contributing the remainder.